𝔖 Bobbio Scriptorium

✦ LIBER ✦

Using biomarkers to assess risk and consider treatment strategies in non-ST-segment elevation acute coronary syndromes

✍ Scribed by Ankie Amos; L. Kristin Newby

Publisher: Springer
Year: 2005
Tongue: English
Weight: 511 KB
Volume: 7
Category: Article
ISSN: 1523-3782
DOI: 10.1007/s11886-005-0047-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Balancing the benefits and risks of anti

Balancing the benefits and risks of antiplatelet agents in patients with non-ST-segment elevated acute coronary syndromes and undergoing percutaneous coronary intervention

✍ Jorge F. Saucedo 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 349 KB

Use of platelet glycoprotein IIb/IIIa in

Use of platelet glycoprotein IIb/IIIa inhibitors in diabetics undergoing PCI for non-ST-segment elevation acute coronary syndromes: impact of clinical status and procedural characteristics

✍ Timm Bauer; Helge Möllmann; Franz Weidinger; Uwe Zeymer; Ricardo Seabra-Gomes; F 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 302 KB